Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Sotera Health Company (NASDAQ: SHC), a leading global provider of sterilization solutions, lab testing, and healthcare advisory services, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Michael B. Petras, Jr. will deliver a presentation on Tuesday, January 14, 2025, at 11:15 a.m. Eastern Time.

The company's senior leadership team, including CFO Jon Lyons and VP of Investor Relations Jason Peterson, will engage in investor meetings throughout the conference. Investors and interested parties can access a live webcast of the presentation through Sotera Health's Investor Relations website section under Presentations & Events. The presentation materials will be available for viewing, and a replay will be accessible within 48 hours after the conference concludes.

CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 43^rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:15 a.m. Eastern Time. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President, Investor Relations and Treasurer, will participate in meetings with investors during the conference.

A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available within 48 hours following the conclusion of the conference and archived on the Company's website.

About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.

INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations & Treasurer
IR@soterahealth.com

MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com

Source: Sotera Health Company

FAQ

When is Sotera Health (SHC) presenting at the 2025 J.P. Morgan Healthcare Conference?

Sotera Health (SHC) will present at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. Eastern Time.

How can investors watch Sotera Health's (SHC) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via live webcast through the Investor Relations section of Sotera Health's website under Presentations & Events.

Which Sotera Health (SHC) executives will attend the 2025 J.P. Morgan Healthcare Conference?

Chairman and CEO Michael B. Petras, Jr., CFO Jon Lyons, and VP of Investor Relations Jason Peterson will attend the conference.

How long will Sotera Health's (SHC) J.P. Morgan presentation replay be available?

The presentation replay will be available within 48 hours after the conference concludes and will be archived on the company's website.